This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Academia Sinica. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovations of Feng-Min Lin
Introduction
Feng-Min Lin is a notable inventor based in Niaosong, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of androgen receptor-associated diseases. His work focuses on the application of certain diterpene compounds, which have shown promise in inhibiting androgen receptor activity.
Latest Patents
Feng-Min Lin holds a patent titled "Use certain diterpene compounds in the treatment of androgen receptor-associated diseases." This invention discloses specific diterpenes that can inhibit androgen receptor activity, induce apoptosis, and block cell cycle progression in androgen receptor-dependent cells. The androgen receptor is linked to various diseases, including prostate cancer, androgenic alopecia, breast cancer, and acne. The patent further outlines methods for treating these diseases by administering the disclosed diterpenes. He has 1 patent to his name.
Career Highlights
Feng-Min Lin is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to explore innovative solutions to complex medical challenges. His research has the potential to impact the treatment of several serious health conditions.
Collaborations
Feng-Min Lin has collaborated with esteemed colleagues such as Pei-wen Hsiao and Sheng-Yang Wang. These collaborations have enriched his research and contributed to the advancement of knowledge in his field.
Conclusion
Feng-Min Lin's innovative work in the treatment of androgen receptor-associated diseases highlights the importance of research in developing new therapeutic strategies. His contributions to the field are significant and pave the way for future advancements in medical science.
